WPD and CNS partner for paediatric brain cancer trial
WPD Pharmaceuticals and CNS Pharmaceuticals are set to initiate a Phase I clinical trial for...
Moleculin augments two anti-cancer clinical trials in Poland
Moleculin has undertaken and enrolled patients in two anti-cancer clinical trials in Poland.
M&As this week: Orion Biotechnology Canada, SOPHiA GENETICS, GI Partners
Orion Biotechnology Canada has completed the acquisition of K2Biomedical for an undisclosed sum.
Deals this week: Ultragenyx Pharmaceutical, Insmed, Harbour BioMed
US-based biopharmaceutical company Ultragenyx Pharmaceutical Inc has announced a public offering of shares of its...